Multaq 400 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FNS3D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,435
Award facts
- Contract value 100% obligated
- $10,434.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 23, 2026, the Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,434.53 for the supply of Multaq (dronedarone) 400 mg tablets in quantities of 60 units. This firm fixed-price, competitively awarded contract (with no set-aside designation) is scheduled for completion by January 26, 2026, with performance based in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor providing critical medical procurement support to federal agencies, particularly the Department of Defense and military healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies. This delivery order for Multaq, an antiarrhythmic medication used in cardiac care, represents a routine task order execution under the broader pharmaceutical prime vendor contract structure that enables efficient and flexible sourcing of essential medications for military treatment facilities and federal healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FNS3D?
SPE2DR26FNS3D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FNS3D worth?
The government has obligated $10,435 on SPE2DR26FNS3D.
Is contract SPE2DR26FNS3D an order under another contract?
Yes. SPE2DR26FNS3D is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNS3D competed?
The extent of competition for SPE2DR26FNS3D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award